SciSparc (SciSparc) Change In Inventory : $-0.07 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is SciSparc Change In Inventory?

SciSparc's change in inventory for the quarter that ended in Dec. 2023 was $-0.08 Mil. It means SciSparc's inventory increased by $0.08 Mil from Jun. 2023 to Dec. 2023 .

SciSparc's change in inventory for the fiscal year that ended in Dec. 2023 was $-0.07 Mil. It means SciSparc's inventory increased by $0.07 Mil from Dec. 2022 to Dec. 2023 .

SciSparc's Total Inventories for the quarter that ended in Dec. 2023 was $0.74 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. SciSparc's Inventory Turnover for the quarter that ended in Dec. 2023 was -0.83.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. SciSparc's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.77.

SciSparc Change In Inventory Historical Data

The historical data trend for SciSparc's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciSparc Change In Inventory Chart

SciSparc Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.67

-0.07

SciSparc Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	0.01	-0.08

SciSparc Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.07 Mil.

SciSparc (OTCPK:SPRCY) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

SciSparc's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.701	/	-0.584	*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

SciSparc's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	-0.584	/	0.701
	=	-0.83

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

SciSparc's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.701	/	0.907
	=	0.77

SciSparc Change In Inventory Related Terms

Thank you for viewing the detailed overview of SciSparc's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

SciSparc (SciSparc) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SciSparc Ltd (OTCPK:SPRCY) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SPRC:USA

Address

20 Raul Wallenberg Street, Tower A, 2nd Floor, Tel Aviv, ISR, 6971916

Website

https://www.scisparc.com

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.